LATEST: VACCINES, LONG COVID & GLP-1 WEIGHT LOSS: 11-13-23

LATEST: VACCINES, LONG COVID & GLP-1 WEIGHT LOSS: 11-13-23

148 View

Publish Date:
14 November, 2023
Category:
COVID-19 Treatments
Video License
Standard License
Imported From:
Youtube

The Good
. Wastewater level low bounce?
. Latest vaccine working with latest variant EG.5
. Vaccines decrease Long Covid risk
. Inhaled infections peaks at 5 seconds
. GLP-1 wonder drug for weight loss and cardiovascular… but LT?

The Bad
. Multiple reinfections increase LT complication and long covid risk
. Ultra processed food: 60% American diet

The Ugly
. Up to 23 million Americans have Long Covid
. Latest clinical update on Long Covid: slow progress

This is a science-based video on the latest scientific research on Omicron to help you make informed decision for yourself and your family. Sources include CDC, FDA, respected scientific data coming from John Hopkins, UCSF, Nature, JAMA and are typically posted on every slide with links.
#covid19 #Variant #LongCovid #moderna #Pfizer #booster #longhauler #reinfection #GLP-1

N95 CDC approved list: https://www.cdc.gov/niosh/npptl/topics/respirators/disp_part/respsource3surgicaln95.html

Check my Time stamp captured text notes: https://tinyurl.com/3zuhwwxz
Check Topic keyword search for video from 6-26-20 to 6-26-22 at https://tinyurl.com/yju9t482


This regular update of the COVID-19, pandemic is narrated by Anne DeGheest. She is leveraging her healthcare network and access to experts with the latest scientific data and publications to paint a reliable picture of the virus' evolution and how it will impact us.

Disclaimer: Anne DeGheest is not a medical doctor and does not intend to provide any medical advice. Her sources are typically posted on every slide with links to published scientific papers and news reports. Please contact your physician before taking any supplements or medications discussed in these videos.

Anne DeGheest pioneered the HealthTech or Digital Health space as a healthcare executive, an entrepreneur, angel investor, corporate advisor and mentor capitalist. She is the founder of HealthTech Capital and MedStars. She launched pulse oximetry with Nellcor and several new hospital patient monitoring companies. Her life science portfolio companies have generated over $18 billion in market capitalization including 8 IPOs. She provided angel capital, hands-on executive leadership and/or business strategy in the founding of major venture-backed companies that changed patient monitoring and hospital care delivery, including the launch of pulse oximetry. She is a well-known keynote speaker and panelist at multiple healthcare conferences. Check her background at https://healthtechcapital.com/degheest